EEG University

DECIDE Study Assessing The Impact of Ceribell EEG – Manuscript Review With Dr. Paul Vespa

Dr. Paul Vespa

Dr. Paul Vespa, Assistant Dean of Critical Care Medicine, Research and David Geffen School of Medicine, UCLA and Gary L. Brinderson Family Chair in Neurocritical Care at David Geffen School of Medicine, UCLA and co-author of the DECIDE paper presents the study.

• Ceribell™ Rapid Response EEG was demonstrated to significantly improve clinical accuracy and confidence

  • A substantial number of critically ill patients with altered mental status have nonconvulsive seizures; data suggests a clear association between prolonged nonconvulsive seizures and poor neurologic outcomes
  • However, even in large academic medical centers with 24/7 in-house EEG technologists, access to conventional EEG is often delayed by several hours
  • Rapid-EEG resulted in substantial changes in physician decision making compared with clinical judgment alone and improved the sensitivity and specificity of physician judgments regarding the presence or absence of nonconvulsive seizure activity
  • Early access to EEG will lead to early detection, and hence, more effective treatment of seizures, which will in turn prevent refractory status epilepticus; neuronal injury; and potentially deleterious impacts on patient morbidity, mortality, and long-term outcome